title: [RESULTS OF LAPAROSCOPIC SURGERY FOR ENDOMETRIAL CANCER: EXPERIENCE OF THE N. N. PETROV RESEARCH INSTITUTE OF ONCOLOGY].
abstract: For the period from September 2010 to September 2014 there were operated 513 patients with endometrial cancer using laparoscopic installation the Karl Storz company. 304 patients (59.2%) underwent hysterectomy with appendages, 209 (40.8%)--hysterectomy with appendages and pelvic lymphadenectomy, including 11 patients (2.2%) with the addition of omentectomy in serous and serous-papillary forms of endometrial cancer. The average age of patients was 58.4 years (44-75 years). Body mass index over 25.0 was determined in 456 patients (88.9%), of whom 183 patients (35.6%) had an excess of body weight, in 159 (31.0%)--obesity of I degree, in 79 (15.5%)--obesity of II degree and in 35 patients (6.8%)--obesity of III degree. There were no reported complications during surgery. The postoperative period in the majority of patients was characterized by the minimal complications and absence of contraindications for adjuvant radiotherapy. During follow-up period there were registered 4 relapses: in 1 patient with serous--papillary form of endometrial cancer during the first year after surgery--in the form of dissemination of tumor in the abdomen and pelvis; in 3 patients--in the form of a cytological detection of glandular cancer cells in vaginal stump. As a result, regardless of age and comorbidities, laparoscopy allows performing to endometrial cancer patients the entire volume of planned radical surgery with minimum damage and with minimal risk of intra- and postoperative complications, favorable and accelerated rehabilitation period.
authors.forename: I V
authors.initials: IV
authors.lastname: Berlev
authors.forename: E A
authors.initials: EA
authors.lastname: Nekrasova
authors.forename: A F
authors.initials: AF
authors.lastname: Urmancheeva
authors.forename: E A
authors.initials: EA
authors.lastname: Ulrikh
authors.forename: N A
authors.initials: NA
authors.lastname: Mikaya
authors.forename: K D
authors.initials: KD
authors.lastname: Guseinov
authors.forename: A B
authors.initials: AB
authors.lastname: Saparov
authors.forename: Yu N
authors.initials: YN
authors.lastname: Trifanov
authors.forename: A A
authors.initials: AA
authors.lastname: Sidoruk
mesh_terms: D000368:Aged; D015992:Body Mass Index; D002291:Carcinoma, Papillary / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D061887:Conversion to Open Surgery; D018284:Cystadenocarcinoma, Serous / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D016889:Endometrial Neoplasms / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000379:methods*; D007431:Intraoperative Complications / Q000209:etiology; D010535:Laparoscopy / Q000009:adverse effects; D008197:Lymph Node Excision; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced; D009367:Neoplasm Staging; D009765:Obesity / Q000150:complications*; D009852:Omentum / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012426:Russia; D016896:Treatment Outcome